Trial Profile
To Evaluate The Efficacy and Safety of Pneumococcal 13-Valent Vaccine in Preventing Respiratory Complications in Pneumococcal Bacteremic Community-Acquired Pneumonia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Aug 2015
Price :
$35
*
At a glance
- Drugs Pneumococcal vaccine (Primary)
- Indications Pneumococcal infections
- Focus Therapeutic Use
- 19 Aug 2015 New trial record